Post by Nigeria mRNA vaccines Consortium (NmRNA-VC)

Malaria: A Persistent Global Health Threat Demanding Innovation and Collaboration Malaria remains one of the world’s most devastating infectious diseases, caused by Plasmodium parasites and transmitted through the bites of infected female Anopheles mosquitoes. Despite decades of control efforts, malaria continues to pose a major public health and socio-economic burden, particularly in low- and middle-income countries. Globally, hundreds of millions of malaria cases are reported each year, with Africa accounting for the overwhelming majority of morbidity and mortality. Nigeria alone contributes a significant proportion of global malaria cases and deaths, underscoring the urgent need for locally driven, evidence-based solutions. Malaria control has traditionally relied on vector control measures, chemoprevention, and effective case management. While these interventions have saved millions of lives, their impact is increasingly threatened by insecticide resistance in mosquito populations, drug resistance in Plasmodium parasites, weak health systems, and climate change–driven changes in vector ecology. Recent advances in science and technology provide renewed opportunities to accelerate malaria control and elimination. Innovations in molecular surveillance, genomics, and digital health are improving understanding of transmission dynamics and resistance patterns. In parallel, the development of malaria vaccines—including emerging mRNA-based vaccine platforms—offers a transformative pathway to complement existing interventions and strengthen long-term disease control. Sustainable malaria elimination cannot be achieved through isolated efforts. It requires integrated, multidisciplinary approaches that link research, innovation, local manufacturing capacity, community engagement, and supportive policy environments. Investment in indigenous research capacity and regional collaboration is particularly critical in high-burden countries. Our consortium is actively open to strategic collaborations and partnerships with academic institutions, industry stakeholders, policymakers, and implementing agencies. We also welcome engagement from interested funders and development partners committed to supporting innovative, locally led solutions for malaria prevention, control, and elimination. Through shared expertise, co-creation, and sustainable financing, malaria elimination can move from aspiration to achievable reality.